Patents by Inventor Christian Büchold

Christian Büchold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of blood coagulation factor XIII
    Patent number: 11472838
    Abstract: The invention relates to a compound of general formula (I) as novel inhibitor of blood coagulation factor XIII, methods for synthesis thereof and to use thereof for the prophylaxis or treatment of diseases associated with blood coagulation factor XIII.
    Type: Grant
    Filed: April 17, 2019
    Date of Patent: October 18, 2022
    Assignee: Zedira GmbH
    Inventors: Martin Hils, Ralf Pasternack, Christian Büchold
  • Inhibitors of transglutaminases
    Patent number: 11072634
    Abstract: The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: July 27, 2021
    Assignee: Zedira GmbH
    Inventors: Martin Hils, Ralf Pasternack, Christian Büchold
  • INHIBITORS OF BLOOD COAGULATION FACTOR XIII
    Publication number: 20210147478
    Abstract: The invention relates to a compound of general formula (I) as novel inhibitor of blood coagulation factor XIII, methods for synthesis thereof and to use thereof for the prophylaxis or treatment of diseases associated with blood coagulation factor XIII.
    Type: Application
    Filed: April 17, 2019
    Publication date: May 20, 2021
    Inventors: Martin Hils, Ralf Pasternack, Christian Büchold
  • INHIBITORS OF TRANSGLUTAMINASES
    Publication number: 20190322700
    Abstract: The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
    Type: Application
    Filed: January 2, 2018
    Publication date: October 24, 2019
    Applicant: Zedira GmbH
    Inventors: Martin Hils, Ralf Pasternack, Christian Büchold